This company listing is no longer active
Vilmorin & Cie Balance Sheet Health
Financial Health criteria checks 3/6
Vilmorin & Cie has a total shareholder equity of €1.4B and total debt of €1.5B, which brings its debt-to-equity ratio to 107.9%. Its total assets and total liabilities are €3.8B and €2.4B respectively. Vilmorin & Cie's EBIT is €151.2M making its interest coverage ratio 4.8. It has cash and short-term investments of €296.0M.
Key information
107.9%
Debt to equity ratio
€1.51b
Debt
| Interest coverage ratio | 4.8x |
| Cash | €296.00m |
| Equity | €1.40b |
| Total liabilities | €2.38b |
| Total assets | €3.78b |
Recent financial health updates
Does Vilmorin & Cie (EPA:RIN) Have A Healthy Balance Sheet?
Mar 03
Vilmorin & Cie (EPA:RIN) Takes On Some Risk With Its Use Of Debt
Mar 16Recent updates
Vilmorin & Cie (EPA:RIN) Has More To Do To Multiply In Value Going Forward
Feb 07Vilmorin & Cie (EPA:RIN) Has More To Do To Multiply In Value Going Forward
Aug 03Is There An Opportunity With Vilmorin & Cie SA's (EPA:RIN) 44% Undervaluation?
Jul 06Is Now An Opportune Moment To Examine Vilmorin & Cie SA (EPA:RIN)?
Jun 14Does Vilmorin & Cie (EPA:RIN) Have A Healthy Balance Sheet?
Mar 03Returns On Capital At Vilmorin & Cie (EPA:RIN) Have Stalled
Feb 10Vilmorin & Cie (EPA:RIN) Is Paying Out A Larger Dividend Than Last Year
Dec 12Is Now The Time To Look At Buying Vilmorin & Cie SA (EPA:RIN)?
Nov 07Vilmorin & Cie (EPA:RIN) Is Increasing Its Dividend To €1.60
Oct 16There's Been No Shortage Of Growth Recently For Vilmorin & Cie's (EPA:RIN) Returns On Capital
Oct 05Is There An Opportunity With Vilmorin & Cie SA's (EPA:RIN) 42% Undervaluation?
Jul 06Vilmorin & Cie (EPA:RIN) Is Doing The Right Things To Multiply Its Share Price
Jun 10At €57.50, Is It Time To Put Vilmorin & Cie SA (EPA:RIN) On Your Watch List?
May 26Calculating The Intrinsic Value Of Vilmorin & Cie SA (EPA:RIN)
Mar 29Vilmorin & Cie (EPA:RIN) Takes On Some Risk With Its Use Of Debt
Mar 16What Do The Returns On Capital At Vilmorin & Cie (EPA:RIN) Tell Us?
Mar 03Here's How We Evaluate Vilmorin & Cie SA's (EPA:RIN) Dividend
Feb 16
Vilmorin & Cie SA's (EPA:RIN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 01At €50.20, Is It Time To Put Vilmorin & Cie SA (EPA:RIN) On Your Watch List?
Jan 19Vilmorin & Cie's (EPA:RIN) Shareholders Are Down 39% On Their Shares
Jan 05Calculating The Intrinsic Value Of Vilmorin & Cie SA (EPA:RIN)
Dec 23Should Income Investors Look At Vilmorin & Cie SA (EPA:RIN) Before Its Ex-Dividend?
Dec 09How Does Vilmorin & Cie's (EPA:RIN) CEO Pay Compare With Company Performance?
Nov 30How Does Vilmorin & Cie SA (EPA:RIN) Fare As A Dividend Stock?
Nov 17Financial Position Analysis
Short Term Liabilities: RIN's short term assets (€1.7B) exceed its short term liabilities (€997.2M).
Long Term Liabilities: RIN's short term assets (€1.7B) exceed its long term liabilities (€1.4B).
Debt to Equity History and Analysis
Debt Level: RIN's net debt to equity ratio (86.8%) is considered high.
Reducing Debt: RIN's debt to equity ratio has increased from 101.6% to 107.9% over the past 5 years.
Debt Coverage: RIN's debt is not well covered by operating cash flow (18.1%).
Interest Coverage: RIN's interest payments on its debt are well covered by EBIT (4.8x coverage).